Alice Zhang

Verge Genomics Announces Oversubscribed $98 Million Series B Funding Round

PRESS RELEASE — Verge Genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (AI) and human data to develop new drugs, announced today it has closed an oversubscribed $98 million equity financing. The Series B financing was led by funds managed by BlackRock and supported by new healthcare and technology investors, including …

Verge Genomics Announces Oversubscribed $98 Million Series B Funding Round Read More »